Cancer screening and tumour marker tests are often confused, and they do very different jobs. Screening tests are designed to find cancer or pre-cancer in people without symptoms, and the recommended ones have been studied in large populations. Tumour marker blood tests mostly help track a cancer that’s already diagnosed. Adding a marker panel to a health checkup is not the same as being screened for cancer.
This guide explains the difference, sets out the screening tests recommended by age and risk, and shows where markers genuinely fit.
The Core Difference
| Screening test | Tumour marker test | |
|---|---|---|
| Purpose | Find cancer or pre-cancer before symptoms | Mostly monitor a diagnosed cancer |
| Who it’s for | Defined age and risk groups | Usually people with a diagnosis, specific symptoms or defined high risk |
| Evidence | Proven to reduce deaths for specific cancers | No mortality benefit shown as general screening |
| Typical method | Imaging, visual exam or tissue sample | Blood test |
| Examples | HPV test, mammography, colonoscopy, low-dose CT | CA-125, CEA, AFP, CA 19-9, CA 15-3 |
The most rigorous review evidence is blunt on this point. A 2025 systematic review of tumour marker use in people without symptoms found consistently low positive predictive value in the general population, false positives that led to imaging, invasive procedures and surgery, and no mortality benefit in large randomised trials.
Cancer Screening in India: What’s Recommended
India’s national Operational Framework for Management of Common Cancers targets the three commonest cancers here, which together account for roughly a third of all cancers in the country. Screening is offered to adults aged 30 to 65, once every five years, free of cost at government Health and Wellness Centres:
- Oral cancer: visual examination of the mouth, for all adults over 30
- Breast cancer: clinical breast examination, for women over 30
- Cervical cancer: visual inspection with acetic acid (VIA), for women over 30
Uptake remains very low: national survey data from 2019–21 showed only a small fraction of eligible women had ever been screened for cervical or breast cancer. Most cancers in India are still found at a later stage as a result.
Screening by Cancer Type
Cervical Cancer
Among the most preventable cancers. HPV testing is now the preferred test in many guidelines for women aged 30 to 65, typically every five years, with Pap (cytology) every three years as an alternative and VIA used in lower-resource settings. HPV vaccination before exposure adds strong protection.
Breast Cancer
ICMR guidance and Indian practice combine monthly breast self-awareness, clinical breast examination by a doctor, and mammography from around age 40 to 45, at intervals your doctor recommends. Women with a strong family history may need to start earlier and may be advised genetic counselling.
Oral Cancer
India carries a very high oral cancer burden, driven largely by tobacco and areca nut. A simple visual and physical examination by a dentist or doctor is the screening method. Anyone using tobacco in any form should be examined regularly, and any ulcer, white or red patch, or restricted mouth opening lasting more than two weeks should be checked immediately.
Colorectal Cancer
Screening usually begins around age 45 to 50 for average-risk adults, using a stool-based test (FIT) at regular intervals or a colonoscopy, which also removes pre-cancerous polyps. Family history or inflammatory bowel disease means earlier and more frequent screening.
Lung Cancer
Low-dose CT screening is recommended only for people with a heavy smoking history, within defined age ranges, under a doctor’s guidance. It isn’t a routine test for non-smokers, and a chest X-ray isn’t an effective screening tool.
Liver Cancer
Surveillance with ultrasound, sometimes with AFP, is recommended for people with cirrhosis or chronic hepatitis B, typically every six months. This is one of the few situations where a tumour marker has a defined surveillance role, and it’s specialist-directed.
Prostate Cancer
PSA testing is a shared decision. Men are generally advised to discuss the benefits and harms with their doctor from around age 50, or earlier with a family history or other risk factors.
Where Tumour Markers Actually Fit
- Monitoring treatment and watching for recurrence after a cancer diagnosis
- Evaluating a specific finding, such as CA-125 when an ovarian mass is already seen on imaging
- Defined high-risk surveillance, such as AFP with ultrasound in chronic liver disease
- Diagnostic workup of symptoms, ordered by a treating doctor
Outside these situations, adding markers to a routine checkup adds cost and false alarms without adding protection.
What a Preventive Checkup Should Cover
A routine health checkup is genuinely valuable for detecting metabolic and organ-related problems early: diabetes, high cholesterol, thyroid disorders, anaemia, and liver and kidney changes. Cancer risk is handled separately, through:
- Age-appropriate screening for the cancers listed above
- A clinical examination and an honest history, including tobacco and alcohol use and family history
- Prompt evaluation of symptoms, rather than waiting for an annual checkup
- Prevention: stopping tobacco in every form, limiting alcohol, maintaining a healthy weight, staying active, and HPV and hepatitis B vaccination
Symptoms That Need Evaluation Now, Not at Your Next Checkup
- A lump anywhere, including the breast, neck or testis
- A mouth ulcer or white or red patch lasting more than two weeks
- Bleeding between periods, after sex or after menopause
- Blood in stool or urine, or a persistent change in bowel habits
- A cough lasting more than three weeks, or coughing blood
- Difficulty swallowing, or persistent hoarseness
- Unexplained weight loss or persistent unexplained fatigue
Screening is for people without symptoms. If you have symptoms, you need evaluation, not a screening test.
Frequently Asked Questions
1. Do cancer marker tests in health checkup packages detect cancer early?
Generally no. Tumour markers have low positive predictive value in people without symptoms, and no mortality benefit has been shown when they’re used as general screening. Proven early detection comes from cancer-specific screening tests such as HPV testing, mammography, colonoscopy and oral examination.
2. What’s the difference between cancer screening and a tumour marker test?
Screening tests look for cancer or pre-cancer in people without symptoms and are proven to reduce deaths for specific cancers. Tumour marker blood tests mainly monitor a diagnosed cancer, evaluate a known finding, or support surveillance in defined high-risk groups.
3. Which cancer screening tests are recommended in India?
India’s national framework offers screening for oral, breast and cervical cancers to adults aged 30 to 65, once every five years. This uses visual oral examination, clinical breast examination and visual inspection with acetic acid, with HPV testing and mammography used where available.
4. At what age should cancer screening start?
In India, oral, breast and cervical cancer screening is targeted at ages 30 to 65. Mammography typically begins around 40 to 45, and colorectal screening around 45 to 50. A family history of cancer often means starting earlier, as advised by your doctor.
5. Which health checkup packages in Pune include cancer marker tests?
Dedicated cancer marker panels include them, while basic full-body checkups usually don’t. Male panels typically carry PSA, CEA, AFP and CA 19-9; female panels carry CA-125, CA 15-3, CEA and AFP. Whichever package you’re looking at, a marker panel complements age-appropriate screening rather than replacing it.
6. Is there a single blood test that screens for all cancers?
No routine blood test screens reliably for all cancers. Multi-cancer early detection blood tests are being studied, but they are not established as standard care. For now, effective early detection depends on cancer-specific screening tests and prompt evaluation of symptoms.
7. Should I get a PSA test in my annual checkup?
PSA testing is a shared decision rather than an automatic inclusion. Men are usually advised to discuss the benefits and limitations with a doctor from around age 50, or earlier with a family history. PSA can rise for several non-cancerous reasons.
8. What should I do if a tumour marker in my report is high?
See a doctor with your complete report. Most raised markers in people without symptoms are caused by non-cancerous conditions such as inflammation, infection or liver disease. Your doctor will usually repeat the test and assess your symptoms, history and examination before ordering anything further.
9. Who should consider tumour marker testing?
People already diagnosed with cancer, people being evaluated for specific symptoms or findings, and defined high-risk groups such as those with chronic hepatitis B or cirrhosis, where AFP is used with ultrasound. In each case a doctor orders the specific marker for a specific reason.
10. Where can I get cancer screening tests and a health checkup in Pune?
Preventive health checkups, pathology and imaging are available at diagnostic centres across Pune, including Fittr Labs in Kharadi. The more important step is reviewing your age, sex, family history and tobacco or alcohol use with a doctor, who can tell you which screening tests you actually need and when.
Screening works best when it matches your age and risk, not the longest test list. Talk to a doctor about what applies to you.
